Drug recall D-0336-2023
Product
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0112-5
Reason for recall
Subpotent Drug
Lots and codes
Lot #: 220552, Exp. 11/2023; 221055, Exp. 04/2024.
Recall details
- Recalling firm
- IBSA PHARMA INC, Parsippany, NJ
- Quantity
- N/A
- Distribution
- Nationwide in the USA.
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 30, 2023
- Terminated
- October 31, 2023
Related products
- Tirosint – drug information
- NDC 71858-0130 Tirosint SOL · Levothyroxine Sodium 100 ug/mL · IBSA Pharma Inc.
- NDC 71858-0140 Tirosint SOL · Levothyroxine Sodium 125 ug/mL · IBSA Pharma Inc.
- NDC 71858-0160 Tirosint SOL · Levothyroxine Sodium 200 ug/mL · IBSA Pharma Inc.
- NDC 71858-0110 Tirosint SOL · Levothyroxine Sodium 25 ug/mL · IBSA Pharma Inc.
- NDC 71858-0112 Tirosint SOL · Levothyroxine Sodium 37.5 ug/mL · IBSA Pharma Inc.
- NDC 71858-0105 Tirosint SOL · Levothyroxine Sodium 13 ug/mL · IBSA Pharma Inc.
- NDC 71858-0117 Tirosint SOL · Levothyroxine Sodium 62.5 ug/mL · IBSA Pharma Inc.
- NDC 71858-0145 Tirosint SOL · Levothyroxine Sodium 137 ug/mL · IBSA Pharma Inc.
- NDC 71858-0120 Tirosint SOL · Levothyroxine Sodium 75 ug/mL · IBSA Pharma Inc.
- NDC 71858-0135 Tirosint SOL · Levothyroxine Sodium 112 ug/mL · IBSA Pharma Inc.
- NDC 71858-0125 Tirosint SOL · Levothyroxine Sodium 88 ug/mL · IBSA Pharma Inc.
- NDC 71858-0115 Tirosint SOL · Levothyroxine Sodium 50 ug/mL · IBSA Pharma Inc.
- NDC 71858-0150 Tirosint SOL · Levothyroxine Sodium 150 ug/mL · IBSA Pharma Inc.
- NDC 71858-0113 Tirosint SOL · Levothyroxine Sodium 44 ug/mL · IBSA Pharma Inc.
- NDC 71858-0155 Tirosint SOL · Levothyroxine Sodium 175 ug/mL · IBSA Pharma Inc.